NDC product
LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE
NDC 24470-965 · Cintex Services, LLC
Key facts
| Product NDC | 24470-965 |
|---|---|
| Proprietary name | LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE |
| Nonproprietary name | LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE |
| Substances | LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE |
| Dosage form | CREAM |
| Route | RECTAL |
| Labeler | Cintex Services, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE] |
| Marketing start | Sep 11, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: